Abstract
Purpose:
To evaluate tumor volume reduction in the follow-up of meningiomas after fractionated stereotactic radiotherapy (FSRT) or linac radiosurgery (RS) by using magnetic resonance imaging (MRI).
Patients and Methods:
In 59 patients with skull base meningiomas, gross tumor volume (GTV) was outlined on contrast-enhanced MRI before and median 50 months (range 11–92 months) after stereotactic radiotherapy. MRI was performed as an axial three-dimensional gradient-echo T1-weighted sequence at 1.6 mm slice thickness without gap (3D-MRI). Results were compared to the reports of diagnostic findings.
Results:
Mean tumor size of all 59 meningiomas was 13.9 ml (0.8–62.9 ml) before treatment. There was shrinkage of the treated meningiomas in all but one patient. Within a median volumetric follow-up of 50 months (11–95 months), an absolute mean volume reduction of 4 ml (0–18 ml) was seen. The mean relative size reduction compared to the volume before radiotherapy was 27% (0–73%). Shrinkage measured by 3D-MRI was greater at longer time intervals after radiotherapy. The mean size reduction was 17%, 23%, and 30% (at < 24 months, 24–48 months, and 48–72 months).
Conclusion:
By using 3D-MRI in almost all patients undergoing radiotherapy of a meningioma, tumor shrinkage is detected. The data presented here demonstrate that volumetric assessment from 3D-MRI provides additional information to routinely used radiologic response measurements. After FSRT or RS, a mean size reduction of 25–45% can be expected within 4 years.
Zusammenfassung
Ziel:
Evaluation der Volumenreduktion von Meningeomen in der Nachbeobachtung nach fraktionierter stereotaktischer Strahlentherapie oder Linac-Radiochirurgie mit Hilfe der Magnetresonanztomographie (MRT).
Patienten und Methodik:
Bei 59 Patienten mit Schädelbasismeningeomen wurde das Tumorvolumen auf den kontrastmittelverstärkten MRT-Aufnahmen vor und im Median 50 Monate (11–92 Monate) nach stereotaktischer Strahlentherapie konturiert. Die MRT wurde als axiale dreidimensionale Gradientenecho-T1-Sequenz mit 1,6 mm Schichtdicke ohne Abstand durchgeführt (3D-MRT). Die Ergebnisse wurden mit den radiologischen Befunden verglichen.
Ergebnisse:
Die mittlere Tumorgröße aller 59 Meningeome betrug vor Strahlentherapie 13,9 ml (0,8–62,9 ml). Mit einer Ausnahme zeigte sich bei allen behandelten Meningeomen eine Größenreduktion. Innerhalb einer medianen Nachbeobachtung von 50 Monaten (11–95 Monate) konnte eine mittlere Volumenreduktion von 4 ml (0–18 ml) gemessen werden. Die mittlere relative Größenreduktion im Vergleich zum Ausgangsvolumen vor Strahlentherapie lag bei 27% (0–73%). Die relative, mittels 3D-MRT gemessene Tumorverkleinerung nahm mit längerem Zeitintervall nach Strahlentherapie zu. Die mittlere Größenreduktion betrug 17%, 23% und 30% (< 24 Monate, 24–48 Monate und 48–72 Monate).
Schlussfolgerung:
Durch die Verwendung der 3D-MRT kann in nahezu allen Meningeomen nach stereotaktischer Strahlentherapie eine Größenreduktion beobachtet werden. In der vorliegenden Arbeit konnte gezeigt werden, dass die volumetrische Bestimmung anhand der 3D-MRT zusätzliche Informationen zur in der Routine eingesetzten Messung des radiologischen Ansprechens bietet. Nach fraktionierter stereotaktischer Strahlentherapie oder Radiochirurgie ist innerhalb von 4 Jahren eine mittlere Größenreduktion von 25–45% zu erwarten.
Similar content being viewed by others
References
Debus J, Pirzkall A, Schlegel W, Wannenmacher M. Stereotactic one-time irradiation (radiosurgery). The methods, indications and results. Strahlenther Onkol 1999;175:47–56.
Debus J, Wuendrich M, Pirzkall A, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 2001;19:3547–53.
Deinsberger R, Tidstrand J, Sabitzer H, et al. LINAC radiosurgery in skull base meningiomas. Minim Invasive Neurosurg 2004;47:333–8.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
Eustacchio S, Trummer M, Fuchs I, et al. Preservation of cranial nerve function following gamma knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years. Acta Neurochir Suppl 2002;84:71–6.
Hakim R, Alexander E 3rd, Loeffler JS, et al. Results of linear accelerator- based radiosurgery for intracranial meningiomas. Neurosurgery 1998;42:446–53.
Henzel M, Gross MW, Hamm K, et al. Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study. Neurosurgery 2006;59:1188–94
Henzel M, Gross MW, Hamm K, et al. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 2006;182:382–8.
Henzel M, Hamm K, Sitter H, et al. Comparison of stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neurinomas according to 3-D tumor volume shrinkage and quality of life. Strahlenther Onkol 2009;185:567–73.
Iliadis G, Selviaridis P, Kalogera-Fountzilla A, et al. The importance of tumor volume in the prognosis of patiens with glioblastoma. Comparison of computerized volumetry and geometric models. Strahlenther Onkol 2009;185:743–50.
Jalali R, Loughrey C, Baumert B, et al. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol) 2002;14:103–9.
Kreil W, Luggin J, Fuchs I, et al. Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry 2005;76:1425–30.
Lee JY, Niranjan A, McInerney J, et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002;97:65–72.
Liscäk R, Kollovä A, Vladyka V, et al. Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir Suppl 2004;91:65–74.
Milker-Zabel S, Zabel A, Schulz-Ertner D, et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61:809–16.
Milker-Zabel S, Zabel-du Bois A, Huber P, et al. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas: long-term experience and review of the literature. Strahlenther Onkol 2006;182:635–40.
Nicolato A, Foroni R, Alessandrini F et al. The role of gamma knife radiosurgery in the management of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2002;53:992–1000.
Park YG, Kim E-Y, Chang JW, et al. Volume changes following gamma knife radiosurgery of intracranial tumors. Surg Neurol 1997;48:488–93.
Pollock BE, Stafford SL, Utter A, et al. Stereotactic radiosurgery provides equivalent tumor control to Simpson grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 2003;55:1000–5.
Selch MT, Ahn E, Laskari A, et al. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2004;59:101–11.
Spiegelmann R, Nissim O, Menhel J, et al. Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 2002;51:1373–9.
Sterzing F, Schubert K, Sroka-Perez G, et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008;184:8–14.
Villavicencio AT, Black PM, Shrieve DC, et al. Linac radiosurgery for skull base meningiomas. Acta Neurochir (Wien) 2001;143:1141–52.
Wiehle R, Koth HJ, Nanko N, et al. On the accuracy of isocenter verification with kV imaging in stereotactic radiosurgery. Strahlenther Oncol 2009;185:325–30.
Zachenhofer I, Wolfsberger S, Aichholzer M, et al. Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery 2006;58:28–36.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Astner, S.T., Theodorou, M., Dobrei-Ciuchendea, M. et al. Tumor Shrinkage Assessed by Volumetric MRI in the Long-Term Follow-Up after Stereotactic Radiotherapy of Meningiomas. Strahlenther Onkol 186, 423–429 (2010). https://doi.org/10.1007/s00066-010-2138-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-010-2138-x